Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;26(5):537-49.
doi: 10.1007/s00482-012-1241-6.

[Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses : a systematic review]

[Article in German]
Affiliations

[Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses : a systematic review]

[Article in German]
G Nübling et al. Schmerz. 2012 Sep.

Abstract

Background: Pharmacological treatment of anxiety is an important part of drug treatment in palliative care. In this review we searched for the current evidence of pharmacological treatment of anxiety in palliative care.

Materials and methods: A systematic search of PubMed, Embase, PsycLIT, PsycINFO, CINAHL for studies of anxiety in palliative care was carried out in January 2012. Furthermore we searched the Cochrane Library, references of literature and leading textbooks. Studies were identified and information was filled in a standardized extraction sheet. Studies have been categorized and anxiety as an endpoint determined.

Results: A total of four controlled studies, three uncontrolled studies, two retrospective studies, one case report, two surveys, one systematic Cochrane review and one unsystematic review were analyzed and included in this review. This indicates an overall low number of studies for the pharmacological treatment of anxiety in palliative care. According to our results, benzodiazepines are the most commonly used drugs in palliative care. However, based on our review, there is no evidence-based recommendation for the therapeutic use in palliative care.

Conclusions: With the existing evidence no general recommendations for pharmacological treatment of anxiety in palliative care can be given. Even for the commonly used benzodiazepines, neuroleptics, antidepressants, antihistamines and beta blockers for the treatment of anxiety no evidence based recommendations can be made. However, these medications are commonly used to treat anxiety in other patient populations and can also be used in palliative care patients. According to our review we cannot recommend a single drug or give recommendations regarding the dosage of drugs. There is a strong need for randomized controlled trials to evaluate the effect of drug treatment of anxiety in palliative care patients. The English full text version of this article will be available in SpringerLink as of November 2012 (under "Supplemental").

PubMed Disclaimer

References

    1. J Am Acad Psychoanal Dyn Psychiatry. 2008 Spring;36(1):181-96 - PubMed
    1. J Pain Symptom Manage. 2005 Aug;30(2):145-53 - PubMed
    1. J Affect Disord. 2012 Dec 10;141(2-3):343-51 - PubMed
    1. Clin Geriatr Med. 1996 May;12(2):329-47 - PubMed
    1. J Pain Symptom Manage. 2011 Nov;42(5):691-701 - PubMed

Publication types

MeSH terms

Substances